Printer Friendly

Anticoagulant drug lowers stroke risk.

People with atrial fibrillation -- an irregular beating pattern of the heart's upper chambers that often develops with age -- experience five times the risk of stroke as individuals with normally beating hearts. A new study now confirms that the anticoagulant warfarin can dramatically lower this risk.

The study -- conducted by more than 100 physicians at 16 Department of Veterans Affairs medical centers across the United States -- is the fifth to demonstrate warfarin's antistroke benefits. Some of the previous studies also suggested that a daily dose of aspirin can reduce stroke risk among patients with atrial fibrillation (SN: 3/24/90, p.180).

In the new study, reported in the Nov. 12 NEW ENGLAND JOURNAL OF MEDICINE, physicians administered either warfarin or a placebo to 571 men between the ages of 60 and 74. Forty-six of the men had already suffered a stroke.

Overall, the researchers found that warfarin treatment reduced the men's stroke risk by 79 percent. Moreover, they found that the drug was just as effective among men over age 70 as among the younger men. Warfarin also appeared to benefit patients who had experienced a previous stroke, although the researchers caution that the number of prior stroke sufferers was too small to support a definitive conclusion.

The researchers suggest that warfarin works by preventing the formation of blood clots within the heart's atrial chambers. Atrial fibrillation fosters such clotting by allowing blood to pool in the heart.

"For the present, all patients with chronic atrial fibrillation should be considered candidates for long-term low-intensity warfarin therapy," cardiologist Daniel E. Singer of the Massachusetts General Hospital in Boston concludes in an editorial accompanying the new report.
COPYRIGHT 1992 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:warfarin can lower risk of atrial fibrillation
Publication:Science News
Article Type:Brief Article
Date:Nov 21, 1992
Previous Article:Abusive inheritance; gene implicated in alcoholism may influence a wide array of drug abuse.
Next Article:Childhood leukemia: a genetic swap meet.

Related Articles
Blood thinners lower risk of stroke for some.
Low TSH: an early warning for stroke.
Widely used drug prevents strokes.
Selected Abstracts [*].
Gene mutation causes heart problems.
Cardioembolic stroke: an update. (Review Article).
Stroke in atrial fibrillation: a need for effective anticoagulation.
Clinical correlation between effective anticoagulants and risk of stroke: are we using evidence-based strategies?
Preventing warfarin-related bleeding.
Beyond Electronic Health Records: quality outcomes management.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters